Analysts think EVGN stock price could increase by 396%
Aug 28, 2024, 6:26 AM
-28.45%
What does EVGN do
Evogene develops a computer-biological platform, the Computational Predictive Biology (CPB), to enhance life sciences products using Big Data and AI. Its subsidiaries focus on therapeutics, medical cannabis, ag-biologicals, and more.
4 analysts think EVGN stock price will increase by 395.63%. The current median analyst target is $17.59 compared to a current stock price of $3.55. The lowest analysts target is $12.12 and the highest analyst target is $23.63.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!